Purpose -The purpose of this paper is to examine knowledge creation and technological diversity management by medical device manufacturers, to identify strategic directions for innovation in the medical device field. Design/methodology/approach -This paper uses two types of data to assess the importance of multiple technologies and technological diversity in product development: patent applications and approvals of medical devices for sale and use in medical treatment. Additional perspective is provided by the results of a survey of management styles. Findings -While knowledge-creating innovation frequently combines multiple technologies, the scope of technological diversity, the variety of types of technology combined may be wider in low-risk than in high-risk innovation.Research limitations/implications -The sample size is too small to justify claims of statistical significance. This research should be extended to incorporate more cases and explore the theme in greater depth. Practical implications -Companies that choose a high-risk strategy are likely to be more focused on related multiple technologies with which their researchers are already familiar. Conversely, companies that choose a low-risk strategy may have more room to experiment since, if something goes wrong, the risk to patient health is lower. Innovative medical device enterprise to seek high-risk device development is proposed to manage optimal diversity for it. Originality/value -This paper analyses two case studies relevant to growing interest in technological diversity and knowledge management in knowledge-driven innovation in the medical device industry in Japan.
The technologies for therapeutic medical devices made in Japan are not highly competitive. Recently, some Japanese companies have achieved breakthroughs in this field. In this study, by using the case of one medical device manufacturer (Terumo), we discuss how the change in the organization affects the creation of knowledge useful for a breakthrough. We focused on the Terumo Business Unit (TBU), which Terumo introduced in 1995 as its business system and analyzed the changes in its patent strategy in comparison with one of its competitors. As a result, an increasing trend in the patentability of the patent applications filed by Terumo after 1995 was observed. An interview regarding the TBU was also conducted. The results suggest that the introduction of the TBU might have intimately affected
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.